All Stories

  1. Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
  2. Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease
  3. Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis
  4. Protein C and Antithrombin III in liver cirrhosis staging
  5. L-Carnitine Supplementation During Hepatitis C Virus Treatment with Sofosbuvir/Daclatasvir Plus Ribavirin: Effect on Anemia: A Pilot Study
  6. Comparative Study Between β-Lactam/β-Lactamase Inhibitors as Alternatives for Carbapenems in the Treatment of Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae
  7. Galectin-3 as a prognostic biomarker for diabetic nephropathy
  8. Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis
  9. Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
  10. Helicobacter pylori infection and risk of salmonella infection
  11. NOD2 expression, DNA damage and oxido-inflammatory status in atopic bronchial asthma: Exploring their nexus to disease severity
  12. Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome
  13. Association of STAT4 polymorphism with susceptibility and severity of rheumatoid arthritis and systemic lupus erythematosus in Egyptian patients
  14. CKS1B/CDKN2C (P18) amplification/deletion as prognostic markers in multiple myeloma patients
  15. Pulmonary hypertension in adult Egyptian patients with b-thalassemia major: correlation with natural anticoagulant levels